NICE approves psoriasis drug

7 July, 2008 | By Steve Ford

NICE has approved adalimumab (Humira) for use as a treatment for chronic plaque psoriasis in adults.

It is currently the only fully human anti-TNF monoclonal antibody licensed for treating plaque psoriasis in the UK.

The drug was recommended by NICE for treating severe active ankylosing spondylitis in May, and it was approved in Scotland for psoriasis last month.

Have your say

You must sign in to make a comment.

sign in register

Related Articles

Related Jobs

Sign in to see the latest jobs relevant to you!

Find more jobs
  • Find hundreds of band 5 nursing jobs on the new Nursing Jobs Express website. All new registrants to the site will be entered into a weekly prize draw to win music, nursing equipment and more
Click here to look for band 5 jobs

Most popular

Most commented

Newsletter Sign-up

More Newsletters

Editorial Image

Online learning for nurses

Nursing Times Learning - a new way for you to update your knowledge and skills. Online units include: appraisal, ABG interpretation, cervical screening, childhood immunisation and more.

Shopping

Off duty

Beat the credit crunch with our ever-changing selection of freebies, discounts and more, exclusively for registered users of nursingtimes.net. Plus Nurses Reunited and Poetry Corner